NASH-TAG 2023 co-course director Stephen Harrison and scientific advisory board committee member Jörn Schattenberg join Louise Campbell and Roger Green to preview what is shaping to be a highly anticipated conference leading the field into a promising New Year.
In light of Madrigal’s announcement of positive topline results from the MAESTRO-NASH trial of resmetirom, the first half of this conversation focuses on Stephen’s assessment of the emerging story. He then provides an overarching walk through of the format and schedule for the event held in Park City, Utah on January 5-7. The group notes there to be a full stack of “wow” presentations embedded in the program in addition to the developing takeaways from Madrigal’s announcement. Jörn looks forward to discourse on what he calls the “next generation of NITs” and Louise highlights an interest in updates on moving pathways forward. Surf on for the full preview and visit the NASH-TAG 2023 website to review this riveting agenda.